Tannic acid induces in vitro acantholysis of keratinocytes via IL-1α and TNF-α

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 289-299

  Feliciani, Claudio ^a   Ruocco, E ^b   Zampetti, A ^a   Toto, P ^c   Amerio, Pa ^c   Tulli, A ^c   Amerio, P ^a   Ruocco, V ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Biochemical acantholysis; Pemphigus; Tannic acid

Indexed keywords

GALLIC ACID; IMMUNOGLOBULIN G; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1ALPHA; TANNIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACANTHOLYSIS; ADULT; APPARATUS; ARTICLE; BLISTER; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEEDING BEHAVIOR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MALE; MEDITERRANEAN DIET; METABOLITE; PEMPHIGUS; PRIORITY JOURNAL;

EID: 34547105772     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000209     Document Type: Article

References (65)

1. Stanley J.R. 2001. Pathophysiology and therapy of pemphigus in the 21st century J. Dermatol. 28:645.
2. Anhalt G.J. and LA. Diaz. 2001. Prospects for autoimmune disease: Research advances in pemphigus. JAMA 285:652.
3. Stanley J.R., T. Nishikawa, L.A. Diaz and M. Amagai. 2001. Pemphigus: is there another half of the story? J. Invest. Dermatol. 116:489.
4. Feliciani C., P. Toto and P. Amerio. 1999. In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1α and TNF-α. J. Cutan. Med. Surg. 3:140.
5. Lapiere J.C., J. Guitart, D.A. Ettlin, D.M. Chen, M. Amagai and L.S. Chan. 1998. Preferential activation of the complement system in the lower epidermis of patients with pemphigus vulgaris. Br. J. Dermatol. 139:851.
6. Lo Muzio L., G. Pannone and S. Staibano. 2002. Strict correlation between uPAR and plakoglobin expression in pemphigus vulgaris. J. Cutan. Pathol. 29:540.
7. Hashimoto K.H., T.C. Wun, J. Baird, G.S. Lazarus and P.J. Jensen. 1989. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J. Invest. Dermatol. 92:310.
8. Caproni M., B. Giomi and C. Cardinali. 2001. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin. Immunol. 98:264.
9. Toto P., C. Feliciani, P. Amerio, H. Suzuki, G. Shivji, B. Wang, D. Woodley and D.N. Sauder. 2000. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. J. Immunol. 164:522.
10. Anhalt G.J., G.O. Till, L.A. Diaz, R.S. Labib, H.P. Patel and N.F. Eaglstein. 1986. Defining the role of complement in experimental pemphigus vulgaris in mice. J. Immunol. 137:2835.
11. Mahoney M.G., Z.H. Wang and J.R. Stanley. 1999. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J. Invest. Dermatol. 113:22.
12. Kalish R.S. 2000. Pemphigus vulgaris: the other half of the story. J. Clin. Invest. 106:1433.
13. Nguyen V.T., A. Ndoye, L.D. Shultz, M.R. Pittelkow and S.A. Grando. 2000. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J. Clin. Invest. 106:1467.
14. Nguyen V.T., A. Ndoye and S.A. Grando. 2000. Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am. J. Pathol. 157:1377.
15. Nguyen V.T., A. Ndoye and S.A. Grando. 2000. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J. Biol. Chem. 275:29466.
16. Grando S.A. 2000. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 201:290.
17. Allen E., Q.C. Yu and E. Fuchs. 1996. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J. Cell. Biol. 133:1367.
18. Hanakawa Y., M. Amagai and Y. Shirakata. 2002. Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. J. Invest. Dermatol. 119:1231.
19. Bezold G., C.A. Sander, M.J. Flaig, R.U. Peter and G. Messer. 2000. Lack of detection of human herpesvirus (HHV)-8 DNA in lesional skin of German pemphigus vulgaris and pemphigus foliaceus patients. J. Invest. Dermatol. 114:739.
20. Tufano M.A., A. Baroni, E. Buommino, E. Ruocco, M.L. Lombardi and V. Ruocco. 1999. Detection of herpesvirus DNA in peripheral blood mononuclear cells and skin lesions of patients with pemphigus by polymerase chain reaction: Br. J. Dermatol. 141:1033.
21. Brenner S., E. Tur and J. Shapiro. 2001. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int. J. Dermatol. 40:562.
22. Jappe U., B. Bonnekoh, B.M. Hausen and H. Gollnick. 1999. Garlic-related dermatoses: case report and review of the literature. Am. J. Contact Dermat. 10:37.
23. Brenner S. and R. Wolf. 1994. Possible nutritional factors in induced pemphigus Dermatology 189:337.
24. Ruocco V., M. Pisani, E. de Angelis and M.L. Lombardi. 1990. Biochemical acantholysis provoked by thiol drugs. Arch. Dermatol. 126:965.
25. Yokel B.K., A.F. Hood and G.J. Anhalt. 1989. Induction of acantholysis in organ explant culture by penicillamine and captopril. Arch. Dermatol. 125:1367.
26. Ruocco V., M. de Luca, M. Pisani, E. de Angelis, O. Vitale and C. Astarita. 1982. Pemphigus provoked by D(-)penicillamine. An experimental approach using in vitro tissue cultures. Dermatologica 164:236.
27. Ruocco V. and G. Sacerdoti. 1991. Pemphigus and bullous pemphigoid due to drugs. Int. J. Dermatol. 30:307.
28. Brenner S., R. Wolf and V. Ruocco. 1993. Drug-induced pemphigus. A survey. Clin. Dermatol. 11:501.
29. Brenner S., A. Bialy-Golan and V. Ruocco. 1998. Drug-induced pemphigus. Clin. Dermatol. 16:393.
30. Ruocco V., E. de Angelis, M.L. Lombardi and M. Pisani. 1988. In vitro acantholysis by captopril and thiopronine. Dermatologica 176:115.
31. De Dobbeleer G., S. Godfrine, J.M. Gourdain, C. De Graef and M. Heenen. 1992. In vitro acantholysis induced by D-penicillamine, captopril, and piroxicam on dead de-epidermized dermis. J. Cutan. Pathol. 19:181.
32. de Angelis E., M.L. Lombardi, M. Grassi and V. Ruocco. 1992. Enalapril: a powerful in vitro non-thiol acantholytic agent. Int. J. Dermatol. 31:722.
33. Lombardi M.L., E. de Angelis, F. Rossano and V. Ruocco. 1993. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis. Dermatology 186:118.
34. Ruocco V., E. de Angelis and M.L. Lombardi. 1993. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin. Dermatol. 11:507.
35. Esposito C., V. Ruocco, A. Cozzolino, A. Lo Schiavo, M.L. Lombardi and R. Porta. 1996. Are acantholysis and transglutaminase inhibition related phenomena? Dermatology 193:221.
36. Esposito C., M.L. Lombardi, V. Ruocco, A. Cozzolino, L. Mariniello and R. Porta. 2000. Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis. Mol. Cell. Biochem. 206:57.
37. Wolf R. and V. Ruocco. 1997. Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Medical Hypotheses 48:107.
38. Brenner S., V. Ruocco, E. Ruocco, A. Russo, E. Tur, V. Luongo and M.L. Lombardi. 2000. In vitro tannin acantholysis. Int. J. Dermatol. 39:738.
39. Kricheli D., M. David, M. Frusic-Zlotkin, D. Goldsmith, M. Rabinov, F. Sulkes, and Y. Milner. 2000. The distribution of pemphigus vulgaris IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br. J. Dermatol. 143:337.
40. Tur E. and S. Brenner. 1998. Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvageum. Arch. Dermatol. 134:1406.
41. Ruocco V., S. Brenner and E. Ruocco. 2001. Pemphigus and diet: does a link exist? Int. J. Dermatol. 40:161.
42. Brenner S., V. Ruocco, R. Wolf, E. de Angelis and M.L. Lombardi. 1995. Pemphigus and dietary factors. In vitro acantholysis by allyl compounds of the genus Allium. Dermatology 190:197.
43. Russo A., R. Acquaviva, A. Campisi, V. Sorrenti, C. Di Giacomo, G. Virgata, M.L. Barcellona and A. Vanella. 2000. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell. Biol. Toxicol. 16:91.
44. de Gaetano G., A. De Curtis, A. di Castelnuovo, M.B. Donati, L. Iacoviello and S. Rotondo. 2002. Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption. Ann. N.Y. Acad. Sci. 957:174.
45. Scalbert A. and G. Williamson. 2000. Dietary intake and bioavailability of polyphenols. J. Nutr. 130:2073.
46. Nakamura Y., S. Tsuji and Y. Tonogai. 2003. Method for analysis of tannic acid and its metabolites in biological samples: application to tannic acid metabolism in the rat. J. Agric. Food Chem. 51:331.
47. Singleton V.L. 1981. Naturally occurring food toxicants. Phenolic substances of plant origin common in foods. Adv. Food Res. 27:149.
48. Bravo L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr.Rev. 56:317.
49. King A. and G. Young. 1999. Characteristics and recurrence of phenolic phytochemicals. J. Am. Diet. Assoc. 99:213.
50. Feliciani C., P. Toto, Pa. Amerio, S. Mohammad Pour, G. Coscione, P. Amerio, G. Shivji, B. Wang and D.N. Sauder. 2000. In vitro and in vivo expression of IL1-α and TNF-α mRNA in Pemphigus Vulgaris: IL1-α and TNF-α are involved in acantholysis. J. Invest. Dermatol. 114:71.
51. Feliciani C., P. Toto, P. Amerio, B. Wang, D.N. Sauder, Pa. Amerio, P. Conti and A. Tulli. 2003. Urokinase Plasminogen Activator (uPA) mRNA is induced by IL-1α and TNF-α in in vitro acantholysis. Exp. Dermatol. 12:466.
52. Hakim I.A., V. Hartz, R.B. Harris, D. Balenatine, U.M. Weisberger, E. Graver, R. Whitacre and D. Alberts. 2001. Reproducibility and relative validity of a questionnaire to assess intake of black tea polyphenols in epidemiological studies. Cancer Epidemiol. Biomark. Prev. 10:667.
53. Feibelman C., G. Stolzner and T.T. Provost. 1981. Pemphigus vulgaris. Superior sensitivity of monkey esophagus in the determination of pemphigus antibody. Arch. Dermatol. 117:561.
54. Barlow Y. and D. Wray. 1991. Ultrastructural alterations associated with in vivo and in vitro bound pemphigus antibodies in cultured oral epithelial cells. J. Oral. Pathol. Med. 20:241.
55. Hashimoto K.H., P.J. Jensen, G.S. Lazarus, S. Morioka and K.H. Singer. 1989. In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody. Immunol. Ser. 46:277.
56. Hunziker T., C. Boillat, H.A. Gerber, U. Wiesmann and B.U. Wintroub. 1989. In vitro pemphigus vulgaris model using organotypic cultures of human epidermal keratinocytes. J. Invest. Dermatol. 93:263.
57. Sedgley C.M., L.P. Samaranayake and B.W. Darvell. 1996. The adherence of oral isolates of Enterobacteriaceae to HeLa cells. An in vitro method using image analysis. APMIS 104:39.
58. Kondo S., T. Kono, D.N. Sauder and R.C. McKenzie. 1993. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J. Invest. Dermatol. 101:690.
59. Bradley K., J. North, D. Saunders, W. Schwaeble, M. Jeziorska, D.E. Wooley and K. Whaley. 1996. Synthesis of classical pathway complement components by chondrocytes. Immunology 88:648.
60. Lanza A., F. Femiano, A. De Rosa, M. Cammarota, M. Lanza and N. Cirillo. 2006. The N-terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: implications for pemphigus vulgaris autoimmunity. Int. J. Immunopathol. Pharmacol. 19:399.
61. Caproni M., D. Torchia, E. Antiga, D. Degl'Innocenti, E. Barletta, G. Baroni, M. Cantucci and P. Fabbri. 2005. The role of apoptosis in the pathogenesis of dermatitis herpetiformis. Int. J. Immunopathol. Pharmacol. 18:691.
62. Puviani M., A. Marconi, E. Cozzani and C. Pincelli. 2003. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J. Invest. Dermatol. 120:164.
63. Kock P.J., M.G. Mahoney and M. Ishikawa. 1997. Targeted disruption of the pemphigus vulgaris antigen (Dsg3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell. Biol. 137:1091.
64. Castellani M.L., V. Salini, S. Frydas, J. Donelan, M. Tagen, B. Madhappan, C. Petrarca, K. Falasca, G. Neri, S. Tetè and J. Vecchiet. 2006. The proinflammatory interleukin-21 elicits antitumor response and mediates autoimmunity. Int. J. Immunopathol. Pharmacol. 19:247.
65. Feliciani C., P. Toto, S. Mohammad Pour, G. Coscione, Pa. Amerio and P. Amerio. 1999. Th2-like cytokine response is involved in bullous pemphigoid: the role of IL-4 and IL-5 in the pathogenesis of the disease. Int. J. Immunopathol. Pharmacol. 12:55.